初代細胞の市場規模、シェア、成長分析、タイプ別、由来別、用途別、最終用途別、地域別- 産業予測、2024～2031年

初代細胞の世界市場規模は、2022年に12億3,000万米ドルと評価され、2023年の13億6,000万米ドルから2031年には30億米ドルに成長し、予測期間中（2024～2031年）のCAGRは10.4％で成長する見通しです。

世界の初代細胞の市場は、細胞ベースの研究に対する需要の高まりと慢性疾患の罹患率の上昇に後押しされ、著しい成長を遂げています。研究者が病態の遺伝的・分子的背景を深く掘り下げるにつれて、初代細胞のニーズが急増し、個々の患者プロファイルに適した標的療法の開発が可能になりました。このような個別化アプローチにより、初代細胞の疾患モデリングや薬剤スクリーニングへの利用が強化され、市場の拡大がさらに加速しています。がん、心血管疾患、神経疾患などの慢性疾患の蔓延により、疾患メカニズムの研究や革新的な治療薬の試験に不可欠なこれらの細胞の需要が増加しています。組織の複雑な生理的環境を忠実に再現する能力を持つ初代細胞は、疾患の病態を理解し、効果的な介入策を考案するために不可欠です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

初代細胞の市場規模：タイプ別& CAGR（2024-2031）

• 市場概要
• 造血細胞
  • 末梢血単核細胞（PBMC）
  • 骨髄細胞
  • 臍帯血細胞
• 皮膚細胞
  • ケラチノサイト
  • メラノサイト
  • 線維芽細胞
• 消化管細胞
  • 結腸上皮細胞
  • 胃上皮細胞
• 肝細胞
  • 肝細胞
  • クッパー細胞
• 肺細胞
  • 肺胞上皮細胞
  • 気管支上皮細胞
• 腎細胞
  • 腎上皮細胞
  • 腎近位尿細管細胞
• その他の細胞
  • 心筋細胞
  • 内皮細胞
  • ニューロン

初代細胞の市場規模：由来別& CAGR（2024-2031）

• 市場概要
• ヒト由来
• 動物由来

初代細胞の市場規模：用途別& CAGR（2024-2031）

• 市場概要
• 調査アプリケーション
  • 医薬品の発見と開発
  • がん研究
  • 免疫学研究
  • 幹細胞研究
• 治療への応用
  • 細胞療法
  • 再生医療

初代細胞の市場規模：最終用途別& CAGR（2024-2031）

• 市場概要
• 学術・研究機関
• 製薬・バイオテクノロジー企業
• 病院および診断研究所
• 細胞バンクと組織バンク

初代細胞の市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Thermo Fisher Scientific Inc.
• Lonza Group AG
• Merck KGaA
• PromoCell GmbH
• Cell Biologics Inc.
• ZenBio Inc.
• STEMCELL Technologies Inc.
• AllCells LLC
• American Type Culture Collection（ATCC）
• Axol Bioscience Ltd.
• Creative Bioarray
• ScienCell Research Laboratories Inc.
• BioIVT
• Corning Incorporated
• Bio-Techne Corporation
• Charles River Laboratories International Inc.
• Cureline Inc.
• Cell Applications Inc.
• iXCells Biotechnologies
• Neuromics

結論と推奨事項

Global Primary Cells Market size was valued at USD 1.23 billion in 2022 and is poised to grow from USD 1.36 billion in 2023 to USD 3.0 billion by 2031, growing at a CAGR of 10.4% during the forecast period (2024-2031).

The global primary cells market is witnessing significant growth propelled by heightened demand for cell-based research and the growing incidence of chronic diseases. As researchers delve deeper into the genetic and molecular underpinnings of conditions, the need for primary cells has surged, allowing for the development of targeted therapies suited to individual patient profiles. This personalized approach has intensified the use of primary cells in disease modeling and drug screening, further stimulating market expansion. The prevalence of chronic diseases, including cancer, cardiovascular, and neurological disorders, has amplified the requirement for these cells, essential for studying disease mechanisms and testing innovative therapeutics. Their capacity to closely replicate the complex physiological environments of tissues makes primary cells critical for comprehending disease pathology and crafting effective interventions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Primary Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Primary Cells Market Segmental Analysis

Global Primary Cells Market is segmented by type, origin, application, end use and region. Based on type, the market is segmented into hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells and other cells. Based on origin, the market is segmented into human primary cells and animal primary cells. Based on application, the market is segmented into research applications and therapeutic applications. Based on end use, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories and cell banks and tissue banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Primary Cells Market

The Global Primary Cells market is experiencing robust growth, primarily fueled by recent advancements in Tissue Engineering and Regenerative Medicine. These innovations have elevated the importance of primary cells in creating engineered tissues and organs intended for transplantation. As the medical community increasingly prioritizes regenerative medicine for its potential to address various health issues, the demand for primary cells has surged. This heightened emphasis on tissue engineering not only enhances the capabilities of medical treatments but also significantly contributes to the overall expansion of the primary cells market, reflecting a promising outlook for future developments in healthcare.

Restraints in the Global Primary Cells Market

The global primary cells market is hindered by the inherent limitation of a short shelf life when compared to immortalized cell lines. As primary cells age, they tend to undergo senescence and may gradually lose their unique characteristics, ultimately resulting in diminished functionality. This reduced lifespan creates significant challenges for storage, transportation, and utilization in extended experimental protocols, which can adversely affect their overall market potential. Consequently, researchers and manufacturers must contend with these limitations, impacting the broader adoption and use of primary cells in various applications and hindering growth within the market.

Market Trends of the Global Primary Cells Market

The Global Primary Cells market is experiencing significant growth driven by the rising demand for personalised medicine. This innovative approach emphasizes tailoring medical treatments to individual patients by leveraging their unique genetic profiles and disease characteristics. Primary cells offer a more authentic representation of human biology, making them essential for researchers and pharmaceutical companies focused on developing targeted therapies and conducting preclinical studies. Their ability to facilitate patient-specific response evaluations enhances drug efficacy and safety assessments, thereby accelerating the adoption of primary cells in drug discovery and development. This trend positions the Global Primary Cells market as a vital component of advancing personalized healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Primary Cells Market Size by By Type & CAGR (2024-2031)

• Market Overview
• Hematopoietic Cells
  • Peripheral Blood Mononuclear Cells (Pbmcs)
  • Bone Marrow Cells
  • Cord Blood Cells
• Skin Cells
  • Keratinocytes
  • Melanocytes
  • Fibroblasts
• Gastrointestinal Cells
  • Colonic Epithelial Cells
  • Gastric Epithelial Cells
• Liver Cells
  • Hepatocytes
  • Kupffer Cells
• Lung Cells
  • Alveolar Epithelial Cells
  • Bronchial Epithelial Cells
• Renal Cells
  • Renal Epithelial Cells
  • Renal Proximal Tubule Cells
• Other Cells
  • Cardiomyocytes
  • Endothelial Cells
  • Neurons

Global Primary Cells Market Size by Origin & CAGR (2024-2031)

• Market Overview
• Human Primary Cells
• Animal Primary Cells

Global Primary Cells Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
  • Drug Discovery and Development
  • Cancer Research
  • Immunology Research
  • Stem Cell Research
• Therapeutic Applications
  • Cell Therapy
  • Regenerative Medicine

Global Primary Cells Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Cell Banks and Tissue Banks

Global Primary Cells Market Size & CAGR (2024-2031)

• North America (Type, Origin, Application, End Use)
  • USA
  • Canada
• Europe (Type, Origin, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Origin, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Origin, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Origin, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Biologics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZenBio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllCells LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection (ATCC)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axol Bioscience Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cureline Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Applications Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iXCells Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuromics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations